M M McNeil

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial
    Nina Marano
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 300:1532-43. 2008
  2. ncbi request reprint Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States Electronic address
    Vaccine 32:4758-65. 2014
  3. doi request reprint Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta GA 30333, United States
    Vaccine 31:2673-9. 2013
  4. doi request reprint A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States
    Vaccine 30:2421-6. 2012
  5. ncbi request reprint Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 33:641-7. 2001
  6. ncbi request reprint A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System
    Michael M McNeil
    Anthrax Vaccine Safety Team, Bacterial Vaccine Preventable Diseases Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, NE, Atlanta, GA 30333, USA
    Vaccine 25:3428-36. 2007
  7. ncbi request reprint Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature
    Michael M McNeil
    Anthrax Vaccine Safety Team, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 16:259-74. 2007
  8. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
  9. pmc Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication
    K Galil
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 5:681-7. 1999
  10. pmc Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
    J Clin Microbiol 37:1398-403. 1999

Collaborators

Detail Information

Publications29

  1. doi request reprint Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial
    Nina Marano
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 300:1532-43. 2008
    ..In 1999, the US Congress directed the Centers for Disease Control and Prevention to conduct a pivotal safety and efficacy study of anthrax vaccine adsorbed (AVA)...
  2. ncbi request reprint Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States Electronic address
    Vaccine 32:4758-65. 2014
    ..In 2011, routine data mining of VAERS identified a vaccine safety concern resulting in acute ischemic cardiac events (ICE) following ACAM2000(®)...
  3. doi request reprint Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta GA 30333, United States
    Vaccine 31:2673-9. 2013
    ..S. licensed vaccines. HCP awareness of and practices regarding reporting of adverse events following immunization (AEFI) is understudied...
  4. doi request reprint A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
    Michael M McNeil
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States
    Vaccine 30:2421-6. 2012
    ..Within 1-2 days, 13 reservists from the same unit presented to the emergency department and 14 filed Vaccine Adverse Event Reporting System (VAERS) reports of nonspecific symptoms following MIV...
  5. ncbi request reprint Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 33:641-7. 2001
    ..These data highlight the public health importance of mycotic diseases and emphasize the need for continuing surveillance...
  6. ncbi request reprint A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System
    Michael M McNeil
    Anthrax Vaccine Safety Team, Bacterial Vaccine Preventable Diseases Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, NE, Atlanta, GA 30333, USA
    Vaccine 25:3428-36. 2007
    ..Our study is the first to quantify the agreement between immunization records in VAERS and DMSS. Our data suggest the immunization information in military VAERS reports and the DMSS is similar for anthrax and non-anthrax immunizations...
  7. ncbi request reprint Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature
    Michael M McNeil
    Anthrax Vaccine Safety Team, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 16:259-74. 2007
    ..While some recent anthrax vaccine safety studies have suggested that women experience more injection site reactions (ISRs), to our knowledge the IND safety data were not previously examined for a gender-specific difference...
  8. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
    ..Our findings underscore the challenges of maintaining stringent infection control practices in the home health care setting and suggest the need for more intensive follow-up and coordination of home TPN therapy among pediatric patients...
  9. pmc Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication
    K Galil
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 5:681-7. 1999
    ..abscessus identical by enzymatic and molecular typing methods. Unusual infectious agents and alternative health practices should be considered in the diagnosis of infections that do not respond to routine treatment...
  10. pmc Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
    J Clin Microbiol 37:1398-403. 1999
    ..We hypothesize that extrinsic contamination of propofol by anesthesiologist 9 likely resulted in C. albicans infections. These data suggest that strict aseptic techniques must be used when preparing and administering propofol...
  11. ncbi request reprint Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits
    B A Lasker
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Cancer for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 39:341-52. 2001
    ..The adaptation and maintenance of an endogenous C. albicans strain within its host may be linked to as yet uncharacterized factors...
  12. ncbi request reprint Outbreak of histoplasmosis among cavers attending the National Speleological Society Annual Convention, Texas, 1994
    D A Ashford
    Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 60:899-903. 1999
    ....
  13. ncbi request reprint Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004
    Daniel C Payne
    Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia, USA
    Pharmacoepidemiol Drug Saf 16:605-11. 2007
    ..S. military from 1998 to 2004...
  14. ncbi request reprint Phenotypic and molecular epidemiologic evaluation of a Nocardia farcinica mastitis epizootic
    June M Brown
    Bacterial Zoonoses Branch, Division of Foodborne, Bacterial and Mycotic Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vet Microbiol 125:66-72. 2007
    ..Our study suggests the epizootic was caused by transmission of a unique clone of N. farcinica through intrinsically contaminated dry cow intramammary products rather than an extrinsic source...
  15. ncbi request reprint Concurrent vaccinations and U.S. military hospitalizations
    Daniel C Payne
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Ann Epidemiol 17:697-703. 2007
    ..To investigate whether concurrent vaccinations (> or =2 vaccinations on consecutive days) are associated with hospitalization risk among U.S. military personnel...
  16. doi request reprint Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004
    Jill C Davila
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States
    Vaccine 26:1577-84. 2008
    ..4%; 95% CI = 80.1, 86.3); most vaccine categories' conditional sensitivities improved over time. Our study suggests DMSS vaccination data may be acceptable for post-marketing vaccine safety studies for certain vaccines and timeframes...
  17. ncbi request reprint Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program
    Gabrielle L Fowler
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 15:880-8. 2006
    ..In 2002, the Advisory Committee on Immunization Practices (ACIP) recommended pre-exposure vaccination for these occupational groups...
  18. ncbi request reprint Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003
    Daniel C Payne
    Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 63:871-5. 2006
    ....
  19. ncbi request reprint Characterization of clinical isolates previously identified as Oerskovia turbata: proposal of Cellulosimicrobium funkei sp. nov. and emended description of the genus Cellulosimicrobium
    June M Brown
    Meningitis and Special Pathogens Branch Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Int J Syst Evol Microbiol 56:801-4. 2006
    ..The definition of this novel Cellulosimicrobium species will assist in the understanding of the epidemiology and clinical significance of these micro-organisms...
  20. pmc Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair species-specific DNA fragment
    June M Brown
    Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious DiseCenters for Disease Control and Prevention, Mail Stop G 34, Atlanta, GA 30333, USA
    J Clin Microbiol 42:3655-60. 2004
    ..Rapid diagnosis of N. farcinica infection may allow for earlier initiation of effective therapy, thus improving patient outcome...
  21. ncbi request reprint Trends in prescribing for vulvovaginal candidiasis in the United States
    Linda F McCaig
    Ambulatory Care Statistics Branch, Division of Health Care Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA
    Pharmacoepidemiol Drug Saf 14:113-20. 2005
    ..Since January 1991, intravaginal antifungal medications have been available over-the-counter in the United States to treat vulvovaginal candidiasis...
  22. ncbi request reprint Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition
    Mark F Schinsky
    Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Int J Syst Evol Microbiol 54:1653-67. 2004
    ..n = 1) and Mycobacterium brisbanense sp. nov. (n = 1), with type strains ATCC 49935T (= W5998T = DSM 44677T), ATCC 49403T (= W5198T = DSM 44676T) ATCC 49404T (= W6705T = DSM 44679T) and ATCC 49938T (= W6743T = DSM 44680T), respectively...
  23. ncbi request reprint An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program
    Stacey W Martin
    Anthrax Vaccine Safety Team, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 14:393-401. 2005
    ..e., ciprofloxacin, doxycycline, or amoxicillin); or (2) 40 additional days of antimicrobial prophylaxis plus three doses of anthrax vaccine adsorbed (AVA)...
  24. pmc Phenotypic and genetic characterization of clinical isolates of CDC coryneform group A-3: proposal of a new species of Cellulomonas, Cellulomonas denverensis sp. nov
    June M Brown
    Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Bldg 17 2207, Mailstop G 34, Atlanta, GA 30333, USA
    J Clin Microbiol 43:1732-7. 2005
    ..hominis serve to further clarify the complex taxonomy of CDC coryneform group A-3 bacteria and will assist in our understanding of the epidemiology and clinical significance of these microorganisms...
  25. ncbi request reprint Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax
    Bruce C Tierney
    Epidemiology Program Office, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 37:905-11. 2003
    ..No SAEs were associated with anthrax vaccine. CDC will continue to monitor Program participants during the next 2 years...
  26. ncbi request reprint Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed
    Daniel C Payne
    Bacterial Vaccine Preventable Diseases Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pharmacoepidemiol Drug Saf 16:46-54. 2007
    ..The focus of this report is to describe the process by which the VAU's anthrax vaccine safety research plan was developed following a comprehensive review of these topics...
  27. ncbi request reprint Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999
    George M Lyon
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 70:438-42. 2004
    ..Persons who explore caves, whether for recreation or science, should be aware of the risk bat-inhabited caves pose for developing histoplasmosis, especially if they are immunocompromised in any way...
  28. pmc Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility
    Natalya U Makarova
    Laboratory of Bacteriology and Mycology, Department of Laboratory Medicine, Russia AIDS Centre, Central Institute of Epidemiology, Moscow, Russia
    J Clin Microbiol 41:1833-7. 2003
    ..There may be a tendency for persons who are living with AIDS in a long-term care facility and who receive fluconazole therapy for oropharyngeal candidiasis to harbor and spread fluconazole-resistant C. albicans strains...
  29. pmc Molecular epidemiologic evaluation of endocarditis due to Oerskovia turbata and CDC group A-3 associated with contaminated homograft valves
    Michael M McNeil
    National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 42:2495-500. 2004
    ..turbata and C. hominis and represent a unique clone of CDC group A-3 associated with fatal endocarditis...